Results 151 to 160 of about 862 (170)

Oncolytic Seneca Valley Virus (SVV-001) Overcomes Checkpoint Inhibitor Resistance and Demonstrates a Systemic Anti-tumor Response in a Syngeneic Tumor Model

Endocrine Abstracts, 2023
Paul L. Hallenbeck, Sunil Chada, Neil Sankar, Aman Chauhan   +3 more
openaire   +2 more sources

Phase I Study of Seneca Valley Virus (SVV-001), A Replication Competent Oncolytic Virus, in Patients with Carcinoid Cancers

Pancreas, 2010
CM Rudin, N Senzer, J Stephenson, K Burroughs, N Senzer, T Williams   +5 more
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Cervical cancer prevention and control in women living with human immunodeficiency virus

Ca-A Cancer Journal for Clinicians, 2021
Philip E Castle, Vikrant V Sahasrabuddhe
exaly  

Seneca Valley Virus Induces DHX30 Cleavage to Antagonize Its Antiviral Effects

Journal of Virology, 2022
Wei Wen, Ping Qian
exaly  

The oncologic burden of hepatitis C virus infection: A clinical perspective

Ca-A Cancer Journal for Clinicians, 2017
Harrys A Torres, Roy F Chemaly, Nassim Hammoudi   +2 more
exaly  

Discovery and Characterization of Essential Viral and Host Proteins for the Oncolytic Seneca Valley Virus (SVV)

, 2016
Linde A. Miles
openalex  

Emergence of novel Seneca Valley virus strains in China, 2017

Transboundary and Emerging Diseases, 2017
Haixue Zheng
exaly  

Seneca Valley virus attachment and uncoating mediated by its receptor anthrax toxin receptor 1

Proceedings of the National Academy of Sciences of the United States of America, 2018
Lin Cao, Mingxu Hu, Lingpeng Cheng
exaly  

Oncolytic Seneca Valley Virus: past perspectives and future directions

Oncolytic Virotherapy, 2016
Michael J Burke
exaly  

Seneca Valley Virus Suppresses Host Type I Interferon Production by Targeting Adaptor Proteins MAVS, TRIF, and TANK for Cleavage

Journal of Virology, 2017
Wenchun Fan, Huawei Zhang, Huanchun Chen
exaly